Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Prime Medicine (PRME) Depreciation & Amortization (CF) (2021 - 2025)

Prime Medicine filings provide 5 years of Depreciation & Amortization (CF) readings, the most recent being $1.9 million for Q4 2025.

  • On a quarterly basis, Depreciation & Amortization (CF) rose 9.26% to $1.9 million in Q4 2025 year-over-year; TTM through Dec 2025 was $7.3 million, a 19.47% increase, with the full-year FY2025 number at $7.3 million, up 19.47% from a year prior.
  • Depreciation & Amortization (CF) hit $1.9 million in Q4 2025 for Prime Medicine, roughly flat from $1.9 million in the prior quarter.
  • In the past five years, Depreciation & Amortization (CF) ranged from a high of $1.9 million in Q3 2025 to a low of $200000.0 in Q3 2021.
  • Median Depreciation & Amortization (CF) over the past 5 years was $1.2 million (2023), compared with a mean of $1.2 million.
  • Biggest five-year swings in Depreciation & Amortization (CF): surged 279.91% in 2022 and later increased 9.26% in 2025.
  • Prime Medicine's Depreciation & Amortization (CF) stood at $229000.0 in 2021, then surged by 279.91% to $870000.0 in 2022, then skyrocketed by 43.33% to $1.2 million in 2023, then soared by 37.69% to $1.7 million in 2024, then increased by 9.26% to $1.9 million in 2025.
  • The last three reported values for Depreciation & Amortization (CF) were $1.9 million (Q4 2025), $1.9 million (Q3 2025), and $1.9 million (Q2 2025) per Business Quant data.